Home > Newsletters > International Pharmaceutical Regulatory Monitor > EC Seeks Faster Turnaround on Pricing, Reimbursement Decisions
International Pharmaceutical Regulatory Monitor
March 2012 | Vol. 40 No. 3
EC Seeks Faster Turnaround on Pricing, Reimbursement Decisions
Drug sponsors may be able to bring novel and generic drugs to market earlier in the EU and be eligible for damages if states don’t meet deadlines for pricing and reimbursement decisions, under proposed legislation adopted by the European Commission March 1.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.